Pharmaceutical Industry Information Portal

HomeNews

News

AGC Biologics Eyeing to Significantly Expand Their Cell and Gene Therapy Capabilities

AGC Biologics announced the signing of a purchase agreement for a state-of-the-art Cell and Gene Therapy commercial manufacturing facility in Longmont, currently owned by Novartis Gene Therapies.

$850 Million investment in FUJIFILM Diosynth Biotechnologies to add additional capacity

Today’s announcement brings the total investments made by Fujifilm in FUJIFILM Diosynth Biotechnologies since 2011 to $5.5B USD (¥600 Billion Yen).

Eleven children receive first dose of Sputnik V in Moscow

After the first and second shots of the vaccine, the teenagers will stay in hospital, in an isolated ward, for three days. Later, they will have to visit the hospital at intervals to undergo tests.

Test batch of the Sputnik V vaccine produced in Mexico

Mexico has become the first country of North America both to register Sputnik V and to launch the local production of the Russian vaccine.

Russia to produce 90 mln anti-COVID-19 vaccine sets by October

We plan to hit the production figure of 30 million sets in July and this figure will be approximately the same for August and September, Manturov said.

GLP system must be viewed by the pharma in a common set with all good practices

The issues pertinent to development of the system of GLP in Russia and the EAEU have been neing discussed over the past several years at the sectoral conferences and thematic round table
spot_img

Expert Articles

spot_img